Carregant...
Everolimus in patients with severe pulmonary hypertension: a safety and efficacy pilot trial
Abstract. Despite the availability of vasodilating compounds, pulmonary hypertension (PH) of various origins remains a disease with a poor prognosis. In recent years, pulmonary arterial hypertension (PAH) has been recognized as a predominantly proliferative process. Everolimus, an inhibitor of the m...
Guardat en:
| Autors principals: | , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
University of Chicago Press
2013
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4070806/ https://ncbi.nlm.nih.gov/pubmed/24618547 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1086/674311 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|